# Surgical Debulking Modifies Notch Signaling and May Improve Vismodegib Effectiveness for Locally Advanced Basal Cell Carcinoma

**Authors:** Natella Maglakelidze, Samantha L. Gettle, Amy L. Longenecker, Allison T. Vidimos, Elizabeth M. Billingsley, Ryan P. Hobbs, Charlene Lam

PMC · DOI: 10.1016/j.xjidi.2024.100288 · JID Innovations · 2024-06-06

## TL;DR

Surgical debulking before vismodegib treatment for basal cell carcinoma may improve outcomes by altering Notch signaling.

## Contribution

This study shows that surgical debulking alters Notch signaling in LaBCC, potentially enhancing vismodegib effectiveness.

## Key findings

- Surgical debulking increases expression of Notch and Wnt signaling genes in LaBCC.
- Elevated Notch signaling was confirmed via immunoblot and immunostaining in post-debulking biopsies.
- Three out of four patients showed clinical response after debulking followed by vismodegib.

## Abstract

Smoothened inhibitors, such as vismodegib, exhibit remarkable success in treating patients with locally advanced basal cell carcinoma (LaBCC). Yet, vismodegib efficacy is hindered by notable side effects, which often lead to treatment discontinuation and subsequent relapse in patients with LaBCC. Prolonged remission was previously reported in patients with LaBCCs who underwent surgical debulking before starting vismodegib. In this study, we enrolled 4 patients with LaBCC who underwent debulking followed by vismodegib therapy to assess their clinical outcomes and analyze the cutaneous molecular changes occurring as a result of surgical intervention. After LaBCC debulking, patients underwent a punch biopsy of residual basal cell carcinoma tissue 1 week later. RT-qPCR analysis of 24 Notch and Wnt signaling–associated genes revealed elevated PTCH1, HEY2, LGR6, FZD2, LEF1, ALCAM, and RUNX1 expressions in follow-up biopsies compared with those in patient-matched debulked tissue. Immunoblot and immunostaining further confirmed elevated Notch signaling in follow-up biopsy tissue compared with that in patient-matched debulked tumor tissue. Patients 1, 3, and 4 displayed a clinical response to debulking followed by vismodegib, whereas patient 2 was lost to follow-up after debulking. These findings suggest that surgical manipulation of LaBCCs is correlated with molecular alterations in signaling pathways associated with cellular reprogramming.

## Linked entities

- **Genes:** PTCH1 (patched 1) [NCBI Gene 5727], HEY2 (hes related family bHLH transcription factor with YRPW motif 2) [NCBI Gene 23493], LGR6 (leucine rich repeat containing G protein-coupled receptor 6) [NCBI Gene 59352], FZD2 (frizzled class receptor 2) [NCBI Gene 2535], LEF1 (lymphoid enhancer binding factor 1) [NCBI Gene 51176], ALCAM (activated leukocyte cell adhesion molecule) [NCBI Gene 214], RUNX1 (RUNX family transcription factor 1) [NCBI Gene 861]
- **Chemicals:** vismodegib (PubChem CID 24776445)
- **Diseases:** basal cell carcinoma (MONDO:0005341)

## Full-text entities

- **Genes:** ALCAM (activated leukocyte cell adhesion molecule) [NCBI Gene 214] {aka CD166, MEMD}, LEF1 (lymphoid enhancer binding factor 1) [NCBI Gene 51176] {aka ECTD1, ECTD17, LEF-1, TCF10, TCF1ALPHA, TCF7L3}, LGR6 (leucine rich repeat containing G protein-coupled receptor 6) [NCBI Gene 59352] {aka GPCR, VTS20631}, RUNX1 (RUNX family transcription factor 1) [NCBI Gene 861] {aka AML1, AML1-EVI-1, AMLCR1, CBF2alpha, CBFA2, EVI-1}, PTCH1 (patched 1) [NCBI Gene 5727] {aka BCNS, BCNS1, NBCCS, PTC, PTC1, PTCH}, FZD2 (frizzled class receptor 2) [NCBI Gene 2535] {aka Fz2, OMOD2, fz-2, fzE2, hFz2}, HEY2 (hes related family bHLH transcription factor with YRPW motif 2) [NCBI Gene 23493] {aka CHF1, GRIDLOCK, GRL, HERP1, HESR2, HRT2}
- **Diseases:** tumor (MESH:D009369), Basal Cell Carcinoma (MESH:D002280)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11287000/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11287000/full.md

## References

18 references — full list in the complete paper: https://tomesphere.com/paper/PMC11287000/full.md

---
Source: https://tomesphere.com/paper/PMC11287000